Miltefosine
CAS No. 58066-85-6
Miltefosine( HePC )
Catalog No. M15130 CAS No. 58066-85-6
Miltefosine is used for the treatment of visceral and cutaneous leishmaniasis, and is undergoing clinical trials for this use in several other countries.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 28 | In Stock |
|
| 100MG | 37 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 83 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMiltefosine
-
NoteResearch use only, not for human use.
-
Brief DescriptionMiltefosine is used for the treatment of visceral and cutaneous leishmaniasis, and is undergoing clinical trials for this use in several other countries.
-
DescriptionMiltefosine is used for the treatment of visceral and cutaneous leishmaniasis, and is undergoing clinical trials for this use in several other countries. Several medical agents have some efficacy against visceral or cutaneous leishmaniasis, however a 2005 survey concluded that miltefosine is the only effective oral treatment for both forms of leishmaniasis.
-
In Vitro——
-
In Vivo——
-
SynonymsHePC
-
PathwayAngiogenesis
-
TargetPKC
-
RecptorPKC
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number58066-85-6
-
Formula Weight407.58
-
Molecular FormulaC21H46NO4P
-
Purity>98% (HPLC)
-
SolubilityEthanol: 82 mg/mL (201.19 mM); Water: 82 mg/mL (201.19 mM)
-
SMILESO=P(OCCCCCCCCCCCCCCCC)([O-])OCC[N+](C)(C)C
-
Chemical Namehexadecyl (2-(trimethylammonio)ethyl) phosphate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Uberall F, et al. Y Res, 1991, 51(3), 807-812.
molnova catalog
related products
-
LY379196
LY379196 is a highly specific PKCβ inhibitor with IC50 of 30-50 nM for PKCβI and PKCβII.
-
LXS196
LXS196 is a potent selective and orally active protein kinase C (PKC) inhibitor(IC50 values of 1.9 nM 0.4 nM and 3.1 μM for PKCα PKCθ and GSK3β respectively).
-
Psychosine
Psychosine (Galactosylsphingosine) is a PKC inhibitor, a substrate for the enzyme galactosylceramide cerebrosidase (GALC), and a potential biomarker of Krabbe's disease.
Cart
sales@molnova.com